We are live on ! Find out more
RXIIW

RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW

Delisted

RXIIW was delisted on the 16th of November, 2018.

Back to rankings

0 hedge funds and large institutions have $0 invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $401K → $0 (-$401K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$255K
2
CH
CVI Holdings
Delaware
-$77K
3
SM
Sabby Management
Florida
-$68K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
– -$77K -221,015 Closed
AFM
2
Anson Funds Management
Texas
– -$255K -218,023 Closed
SM
3
Sabby Management
Florida
– -$68K -195,259 Closed
LTFS
4
Ladenburg Thalmann Financial Services
Florida
– -$1K -3,000 Closed

RXIIW Hedge Fund Activity: Q4 2018 in Review

0 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q4 2018, worth a combined $0 — down 100% from $401K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RXIIW and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Anson Funds Management, exiting entirely with an estimated $255K sold.

  • 0 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q4 2018, down from 4 in Q3 2018.
  • Funds reported $0 of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q4 2018, down 100% quarter-over-quarter.
  • 0 funds opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q4 2018 and 4 closed out, a net change of -4 holders.
  • The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 seller in Q4 2018 was Anson Funds Management, an estimated $255K sold.

Based on aggregated 13F filings for Q4 2018.